COB Columbia Laboratories Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : COB Columbia Laboratories

COB 14.10

0.0%

Nov 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sally bananas who wrote (614)	3/2/2000 2:33:00 PM
From: Emil Veakis	Read Replies (1) of 634

Hi Sally. Quite bullish for one who has been with this co since 97. On a related note, today's Financial Times, p.16 carried an article on Ares-Serono. 1999 net income boost of 62%. Will be changing co name to Serono. Article states that the co has an estimated 60% of the infertility market. Sales of its Gonal-F drug increased by 42% in prior year. Its Rebif is claimed to be the fastest growing drug in the treatment of MS and Serostim gaining in the treatment of AIDS. According to the article, Serono is often rumored to be a takeover target (currently controlled by the Bertarelli family). COB sounds like a nice fit and in any event the relationship is, I believe, beneficial. PR-wise COB is far too quiet - what else is new. I'm content to sit and watch.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next